HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Elastosis perforans serpiginosa

A condition characterized by transepidermal elimination of ELASTIC TISSUE and the development of lesions in a serpiginous pattern, where scar tissue is deposited beneath the dermis. It occurs in several connective tissue disorders including MARFAN SYNDROME; EHLERS-DANLOS SYNDROME; OSTEOGENESIS IMPERFECTA; PSEUDOXANTHOMA ELASTICUM as well as DOWN SYNDROME. It may also occur in isolation as autosomal dominant genetic trait. OMIM: 130100
Also Known As:
Elastoma intrapapillare perforans verruciformis; Miescher elastoma
Networked: 65 relevant articles (6 outcomes, 2 trials/studies)

Relationship Network

Disease Context: Research Results

Related Diseases

1. Hepatolenticular Degeneration (Wilson's Disease)
2. Pseudoxanthoma Elasticum (Gronblad Strandberg Syndrome)
3. Skin Diseases (Skin Disease)
4. Cutis Laxa
5. Down Syndrome (Down's Syndrome)

Experts

1. Chen, Lianjun: 2 articles (07/2016 - 03/2015)
2. Liang, Jun: 2 articles (07/2016 - 03/2015)
3. Wang, Duoqin: 2 articles (07/2016 - 03/2015)
4. Xu, Jinhua: 2 articles (07/2016 - 03/2015)
5. Heusinkveld, Lauren E: 1 article (12/2021)
6. Lucas, Jennifer: 1 article (12/2021)
7. Michalik, Daniel: 1 article (12/2021)
8. Enos, Tyler: 1 article (05/2021)
9. Rainwater, Yevgeniya: 1 article (05/2021)
10. Vandergriff, Travis: 1 article (05/2021)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Elastosis perforans serpiginosa:
1. Penicillamine (Cuprimine)FDA Link
2. ElastinIBA
3. NitrogenIBA
4. Isotretinoin (Accutane)FDA LinkGeneric
5. 1-phenyl-3,3-dimethyltriazene (PDT)IBA
6. CollagenIBA
7. AcitretinFDA Link
8. Imiquimod (Aldara)FDA LinkGeneric
9. Cyclosporine (Ciclosporin)FDA LinkGeneric
10. Biomarkers (Surrogate Marker)IBA

Therapies and Procedures

1. Therapeutics
2. Dye Lasers
3. Cryotherapy (Therapy, Cold)
4. Lasers (Laser)
5. Gas Lasers